Auxilium Pharmaceuticals

Seite 1 von 1
neuester Beitrag: 09.10.14 12:49
eröffnet am: 26.06.14 14:03 von: Capret Anzahl Beiträge: 8
neuester Beitrag: 09.10.14 12:49 von: Capret Leser gesamt: 8694
davon Heute: 6
bewertet mit 5 Sternen

26.06.14 14:03
5

592 Postings, 3985 Tage CapretAuxilium Pharmaceuticals

http://auxilium.com/


About Auxilium

Auxilium is a fully integrated specialty biopharmaceutical company focused on developing and marketing products to predominantly specialist audiences. Auxilium means "assistance" in Latin, and that"s a fitting description for all of our biopharmaceutical development and commercialization efforts.


Auxilium Pharmaceuticals—Dedicated to innovations for life

Although we are living in an era of rapid advances in medical technology, many of society"s medical concerns remain unaddressed. Auxilium works to address some of these unmet needs.

By doing so, we work in important areas of the pharmaceutical industry that require forward thinking and novel solutions that promote better health and living.

Through advancement and expansion, Auxilium is dedicated to providing innovative solutions for underserved diseases that improve health and quality of life.


 

26.06.14 14:04
7

592 Postings, 3985 Tage CapretAuxilium Pipeline

 
Angehängte Grafik:
auxl_pipe.png (verkleinert auf 80%) vergrößern
auxl_pipe.png

26.06.14 14:09
7

592 Postings, 3985 Tage CapretPre

Angehängte Grafik:
auxl.png (verkleinert auf 52%) vergrößern
auxl.png

26.06.14 14:24
7

592 Postings, 3985 Tage CapretShort Interest

 
Angehängte Grafik:
chart.png (verkleinert auf 63%) vergrößern
chart.png

17.09.14 15:40
1

108 Postings, 3800 Tage Cephei?

Premarket in USA zog gut an, scheint so weiterzugehen erstmal :)  

09.10.14 12:49
8

592 Postings, 3985 Tage CapretEndo To Acquire Auxilium

- Auxilium Shareholders to Receive $33.25 Per Share

- Combination Designed to Create Leading Specialty Healthcare Company with Expanded Platform for Future Growth

- Addition of Auxilium's Leading Men's Health Products and Development Portfolio Expected to Significantly Enhance Endo's Branded Pharmaceutical Business

- Transaction Expected to be Immediately Accretive

- Endo Expects to Generate up to $175 Million of Annual Run Rate Operating Expense Reductions Inclusive of the $75 Million of Reductions Previously Announced by Auxilium
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
AUXL Auxilium Pharmaceuticals, Inc. (MM) Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
 

   Antwort einfügen - nach oben